Pembrolizumab in Early Triple-Negative Breast Cancer

  • Schmid, Peter M.D., Ph.D.
  • Cortes, Javier M.D., Ph.D.
  • Dent, Rebecca M.D.

  • 1Queen Mary University of London, London, United Kingdom [email protected]

    2International Breast Cancer Center, Barcelona, Spain

    3National Cancer Center Singapore, Singapore, Singapore

Since publication of their article, the authors report no further potential conflict of interest.

New England Journal of Medicine 386(18):p 1771-1772, May 5, 2022.
Copyright © 2022 Massachusetts Medical Society. All rights reserved.
View full text|Download PDF